3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Rituximab
4
Cyclophosphamide
4
pirtobrutinib
3
fludarabine
2
Chlorambucil
2
venetoclax
1
ofatumumab
1
idelalisib
1
ibrutinib
1
fludarabine phosphate
1
acalabrutinib
1
Valganciclovir
1
Thiotepa
1
Sirolimus
1
Radiotherapy
1
Prednisone
1
Pneumococcal Vaccines
1
Pentostatin
1
Filgrastim
1
Everolimus
1
Biopsy, Needle
1
Bendamustine Hydrochloride
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Valganciclovir
×
Clear all
NCT01255644
2015-07-21
VGCV-CLL
Medical University of Vienna
Phase 4
Completed
20 enrolled